|
| Group I (Control) | Group IIa (Diabetic 4W) | Group IIb (Diabetic 8W) | P value | |||
|
| No. | % | No. | % | No. | % | |
| Smooth muscle mass |
|
|
|
|
|
| <0.001* |
| Normal | 20 | 100.0 | 0 | 0.0 | 0 | 0.0 | |
| Mild decrease | 0 | 0 | 7 | 35.0 | 0 | 0.0 | |
| Moderate decrease | 0 | 0 | 8 | 40.0 | 3 | 15.0 | |
| Total loss | 0 | 0 | 5 | 25.0 | 17 | 85.0 | |
| Corporal fibrosis |
|
|
|
|
|
| |
| No fibrosis | 20 | 100.0 | 0 | 0.0 | 0 | 0.0 | <0.001* |
| Mild | 0 | 0.0 | 9 | 45.0 | 0 | 0.0 | |
| Moderate | 0 | 0.0 | 6 | 30.0 | 4 | 20.0 | |
| Dense | 0 | 0.0 | 5 | 25.0 | 16 | 80.0 | |
| Significance between groups | P1 < 0.001*, P2 < 0.001*, P3 < 0.001* (muscle mass) P1 < 0.001*, P2 < 0.001*, P3 = 0.001* (fibrosis) |
| |||||